From pharmaceutical standardizing to clinical research: 20 years of experience with fifty-millesimal potencies

Authors

  • Ubiratan Cardinalli Adler Faculdade de Medicina de Jundiaí, São Paulo/Brazil
  • Amarilys de Toledo Cesar Faculdade de Medicina de Jundiaí, São Paulo/Brazil
  • Maristela Schiabel Adler Faculdade de Medicina de Jundiaí, São Paulo/Brazil
  • Ana Elisa Padula Faculdade de Medicina de Jundiaí
  • Erika Nakabara Garozzo Faculdade de Medicina de Jundiaí, São Paulo/Brazil
  • Wania Papile Galhardi Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Keywords:

Homeopathy, LM (Q) dilutions, Organon 6th edition, clinical-pharmaceutical protocol, medical education, randomized double-blind clinical trial

Abstract

Background: 20 years ago we began to standardize the procedures of preparation and use of fifty-millesimal dilutions (LM or Q) according to indications in the 6th edition of Hahnemann’s Organon. Aim: to describe the main stages in standardization as well as our teaching and research experience on Organon 6th edition. Results: with the use of standardized LM dilutions we observed a lower incidence of homeopathic aggravation than with our earlier experience with non standardized preparations. Organon.modus, a clinical-pharmaceutical protocol derived from the standardization was adequate for the teaching of homeopathy at Faculty of Medicine of Jundiai (São Paulo), the first Brazilian medical school with a graduate course on homeopathy. A randomized double-blind trial comparing individualized homeopathic medicines prescribed in LM dilutions and fluoxetine showed the former not be inferior to the latter in the treatment of moderate-to-severe depression. Conclusion: protocol Organon.modus showed to be adequate to graduate-level teaching of homeopathy and efficient in a controlled clinical trials, favoring its use as common denominator between the art of healing and medical science.

Author Biographies

Ubiratan Cardinalli Adler, Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Amarilys de Toledo Cesar, Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Secretary for Pharmacy, LMHI

Maristela Schiabel Adler, Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Ana Elisa Padula, Faculdade de Medicina de Jundiaí

Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Erika Nakabara Garozzo, Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Wania Papile Galhardi, Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Faculdade de Medicina de Jundiaí, São Paulo/Brazil

Downloads

Published

2009-12-13

Issue

Section

Clinical Research

Most read articles by the same author(s)